OLA SAYED M. ALI, et al. “Assessment of Circulating Fibroblast Growth Factor 23 in Type 2 Diabetic Patients With Nephropathy”. International Journal of Pharma and Bio Sciences, vol. 8, no. 3, Sept. 2017, pp. 239-46, doi:10.22376/ijpbs.2017.8.3.b239-246.